Apple Hit With $634M Verdict in Apple Watch Blood Oxygen Case

Apple Hit With $634M Verdict in Apple Watch Blood Oxygen Case

Apple Hit With $634 Million Verdict in Apple Watch Blood Oxygen Patent Lawsuit Apple has been hit with a $634 million verdict in the Apple Watch blood oxygen patent lawsuit, raising questions about the company’s innovation strategy and legal challenges. The ruling stems from a patent dispute with medical technology firm Masimo, which claimed Apple infringed on its blood oxygen-sensing technology. Apple plans to appeal the decision, continuing a long-running legal battle over wearable health technology. Image : Google What Led to the Apple Watch Blood Oxygen Patent Verdict? The lawsuit focused on a patent Masimo holds for blood oxygen monitoring technology. According to Masimo, Apple’s Watch Series models violated their intellectual property, prompting the $634 million award. While Apple maintains that most of Masimo’s patent claims were invalid and the key patent expired in 2022, the jury sided with Masimo, underscoring the stakes in wearable health tech IP disputes. How Did Apple Respond …